RUA Life Sciences plc (AIM:RUA)
London
· Delayed Price · Currency is GBP · Price in GBX 12.63
-0.12 (-0.99%)
Jun 27, 2025, 4:35 PM GMT+1
RUA Life Sciences Income Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Operating Revenue | 4.11 | 2.19 | 2.18 | 1.63 | 1.53 | Upgrade
|
| Revenue | 4.11 | 2.19 | 2.18 | 1.63 | 1.53 | Upgrade
|
| Revenue Growth (YoY) | 87.72% | 0.55% | 34.09% | 6.35% | 212.47% | Upgrade
|
| Cost of Revenue | 0.94 | 0.48 | 0.45 | 0.35 | 0.28 | Upgrade
|
| Gross Profit | 3.17 | 1.72 | 1.73 | 1.27 | 1.25 | Upgrade
|
| Selling, General & Admin | 4.16 | 2.48 | 2.61 | 2.17 | 2.82 | Upgrade
|
| Research & Development | - | 0.87 | 1.07 | 0.91 | - | Upgrade
|
| Other Operating Expenses | -0.97 | -0.06 | -0.01 | 0.22 | -0.28 | Upgrade
|
| Operating Expenses | 3.19 | 3.65 | 4.03 | 3.62 | 2.8 | Upgrade
|
| Operating Income | -0.02 | -1.94 | -2.31 | -2.35 | -1.55 | Upgrade
|
| Interest Expense | - | -0.08 | -0.02 | -0.01 | -0.04 | Upgrade
|
| Interest & Investment Income | 0.01 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -0.01 | -2.02 | -2.32 | -2.36 | -1.59 | Upgrade
|
| Pretax Income | -0.01 | -2.02 | -2.32 | -2.36 | -1.59 | Upgrade
|
| Income Tax Expense | -0.01 | -0.58 | -0.32 | -0.29 | -0.14 | Upgrade
|
| Earnings From Continuing Operations | 0 | -1.44 | -2 | -2.07 | -1.45 | Upgrade
|
| Net Income | 0 | -1.44 | -2 | -2.07 | -1.45 | Upgrade
|
| Net Income to Common | 0 | -1.44 | -2 | -2.07 | -1.45 | Upgrade
|
| Shares Outstanding (Basic) | 62 | 34 | 22 | 22 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 62 | 34 | 22 | 22 | 18 | Upgrade
|
| Shares Change (YoY) | 85.00% | 51.21% | - | 25.36% | 20.50% | Upgrade
|
| EPS (Basic) | 0.00 | -0.04 | -0.09 | -0.09 | -0.08 | Upgrade
|
| EPS (Diluted) | 0.00 | -0.04 | -0.09 | -0.09 | -0.08 | Upgrade
|
| Free Cash Flow | -0.28 | -1.38 | -1.6 | -3.26 | -2.03 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.04 | -0.07 | -0.15 | -0.12 | Upgrade
|
| Gross Margin | 77.12% | 78.32% | 79.30% | 78.22% | 81.94% | Upgrade
|
| Operating Margin | -0.49% | -88.41% | -105.83% | -144.74% | -101.50% | Upgrade
|
| Profit Margin | 0.02% | -65.72% | -91.92% | -127.20% | -94.96% | Upgrade
|
| Free Cash Flow Margin | -6.83% | -63.12% | -73.20% | -200.43% | -133.12% | Upgrade
|
| EBITDA | 0.4 | -1.57 | -1.95 | -2.04 | -1.3 | Upgrade
|
| EBITDA Margin | 9.75% | -71.79% | -89.40% | -125.72% | -84.88% | Upgrade
|
| D&A For EBITDA | 0.42 | 0.36 | 0.36 | 0.31 | 0.25 | Upgrade
|
| EBIT | -0.02 | -1.94 | -2.31 | -2.35 | -1.55 | Upgrade
|
| EBIT Margin | -0.49% | -88.41% | -105.83% | -144.74% | -101.50% | Upgrade
|
| Advertising Expenses | - | 0.01 | 0.02 | 0.01 | - | Upgrade
|
Updated Dec 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.